United States Food and Drug Administration-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2019

  1. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

    The Lancet Respiratory Medicine, Vol. 7, Núm. 11, pp. 951-963